MapLight Therapeutics
MapLight Therapeutics develops circuit-specific pharmacotherapies for central nervous system disorders.
SCHEDULE 13G/ANov 16Latest SEC filing
Nov 16Latest story
November 2026
September 2026
August 2026
July 2026
MapLight Therapeutics develops circuit-specific pharmacotherapies for central nervous system disorders.
November 2026
September 2026
August 2026
July 2026